FDA Inspection 1262846 — Department of Defense - Army

Department of Defense - Army — FEI 1000523903

The FDA completed an inspection of Department of Defense - Army on February 26, 2025 in Tacoma, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 26, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tacoma, WA (United States)